Delivery Order SPE2DB22D1017-SPE2DB24FG3RS
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,295,902 units of the prescription medication Dupixent 300 mg/2 ml pen (2 ml). The contract has a firm fixed price of $20,064.68 and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,746.47 firm-fixed-price contract is for the supply of Dupixent 300 mg/2 ml pens, with a period of performance through December 10, 2024. The contract is not designated as a set-aside and represents a single delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a $56,588.57 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the medication Dupixent 300 mg/2 ml pen, with an ultimate completion date of August 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $10,256.76, is for the medication Dupixent 300 mg/2 ml pen, 2 ml. The contract is a firm-fixed-price delivery order with a completion date of May 21, 2025. It is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $10,618.06 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a large pharmaceutical distributor. The contract is for the supply of 4,565,295,219 units of the specialty medication Dupixent 300 mg/2 ml pens, with a period of performance through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a $36,916.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the drug Dupixent 300 mg/2 ml pen, with a period of performance through April 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,852.75, is for the delivery of Dupixent 300 mg/2 ml pens. The contract is a firm fixed-price delivery order with a completion date of December 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,452.32 order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,981.00 firm fixed-price contract is for the supply of Dupixent 300 mg/2 mL pens, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of November 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...